NASDAQ:RLMD

Relmada Therapeutics Earnings Date, Estimates & History

$34.23

+1.01 (+3.04 %)

(As of 03/5/2021 12:00 AM ET)

Add

Compare

Today's Range

$31.56

Now: $34.23▼

$34.32

50-Day Range

$31.52

MA: $35.16▼

$38.46

52-Week Range

$23.25

Now: $34.23▼

$54.00

Volume81,053 shs

Average Volume79,411 shs

Market Capitalization$555.96 million

P/E RatioN/A

Dividend YieldN/A

Beta0.53

Relmada Therapeutics Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Relmada Therapeutics (NASDAQ:RLMD) Earnings Estimates

2021 EPS Consensus Estimate: ($4.78)

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2021	4	($1.54)	($0.45)	($0.99)
Q2 2021	4	($1.68)	($0.48)	($1.09)
Q3 2021	3	($1.93)	($0.87)	($1.34)
Q4 2021	3	($2.01)	($0.95)	($1.35)
Q1 2022	1	($1.23)	($1.23)	($1.23)
Q2 2022	1	($1.09)	($1.09)	($1.09)

Relmada Therapeutics (NASDAQ RLMD) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Reported EPS	GAAP EPS	Conference Call
8/12/2020	Q2 2020	($0.55)	($0.73)	($0.73)	N/A
8/12/2020	Q2 2020	($0.55)	($0.73)	($0.73)	N/A
8/12/2020	Q2 2020	($0.55)	($0.73)	($0.73)	N/A
5/15/2020	Q1 2020	($0.33)	($0.72)	($0.72)	N/A
5/15/2020	Q1 2020	($0.33)	($0.72)	($0.72)	N/A
5/15/2020	Q1 2020	($0.33)	($0.72)	($0.72)	N/A
11/13/2019	Q3 2019		($0.38)	($0.38)	N/A
11/13/2019	Q1 2020		($0.38)	($0.38)	N/A
11/13/2019	Q1 2020		($0.38)	($0.38)	N/A
9/24/2019	Q2 2019		($0.44)	($0.44)	N/A

9/24/2019	Q4 2019		($0.44)	($0.44)	N/A
9/24/2019	Q4 2019		($0.44)	($0.44)	N/A
5/14/2019	Q1 2019		($0.36)	($0.36)	N/A
5/14/2019	Q3 2019		($0.36)	($0.36)	N/A
5/14/2019	Q3 2019		($0.09)	($0.09)	N/A
2/13/2019	Q4 2018		($1.12)	($1.12)	N/A
2/13/2019	Q2 2019		($1.12)	($1.12)	N/A
2/13/2019	Q2 2019		($0.28)	($0.28)	N/A
11/13/2018	Q3 2018		($1.08)	($1.08)	N/A
11/13/2018	Q1 2019		($1.08)	($1.08)	N/A
11/13/2018	Q1 2019		($0.27)	($0.27)	N/A
5/14/2018	Q1 2018		($1.04)	($1.04)	N/A
5/14/2018	Q3 2018		($1.04)	($1.04)	N/A
5/14/2018	Q3 2018		($0.26)	($0.26)	N/A
2/12/2018	Q4 2017		($0.44)	($0.44)	N/A
2/12/2018	Q2 2018		($0.44)	($0.44)	N/A
2/12/2018	Q2 2018		($0.11)	($0.11)	N/A
11/14/2017	Q3 2017		($0.32)	($0.32)	N/A
11/14/2017	Q1 2018		($0.32)	($0.32)	N/A
11/14/2017	Q1 2018		($0.08)	($0.08)	N/A
9/28/2017	Q2 2017		($0.52)	($0.52)	N/A
9/28/2017	Q4 2017		($0.52)	($0.52)	N/A
9/28/2017	Q4 2017		($0.13)	($0.13)	N/A
5/15/2017	Q1 2017		($0.64)	($0.64)	N/A
5/15/2017	Q3 2017		($0.64)	($0.64)	N/A
5/15/2017	Q3 2017		($0.16)	($0.16)	N/A
2/10/2017	Q4 2016		($0.36)	($0.36)	N/A
2/10/2017	Q2 2017		($0.36)	($0.36)	N/A
2/10/2017	Q2 2017		($0.09)	($0.09)	N/A
11/10/2016	Q3 2016		($0.56)	($0.56)	N/A
11/10/2016	Q1 2017		($0.56)	($0.56)	N/A
11/10/2016	Q1 2017		($0.14)	($0.14)	N/A
9/9/2016	Q2 2016	($0.72)	($1.16)	($1.16)	N/A
9/9/2016	Q4 2016	($0.72)	($1.16)	($1.16)	N/A
9/9/2016	Q4 2016	($0.18)	($0.29)	($0.29)	N/A
5/9/2016	Q1 2016	($1.56)	($0.60)	($0.60)	N/A
5/9/2016	Q3 2016	($1.56)	($0.60)	($0.60)	N/A
5/9/2016	Q3 2016	($0.39)	($0.15)	($0.15)	N/A
2/5/2016	Q4 2015	($1.68)	($0.88)	($0.88)	N/A
2/5/2016	Q2 2016	($1.68)	($0.88)	($0.88)	N/A
2/5/2016	Q2 2016	($0.42)	($0.22)	($0.22)	N/A
11/6/2015	Q3 2015		$1.44	$1.44	N/A
11/6/2015	Q1 2016		$1.44	$1.44	N/A
11/6/2015	Q1 2016		$0.36	$0.36	N/A
5/15/2015	Q2 2015		($0.20)	($0.20)	N/A
5/15/2015	Q4 2015		($0.20)	($0.20)	N/A
5/15/2015	Q4 2015		($0.05)	($0.05)	N/A

(Earnings results data provided by Zacks Investment Research)

This page was last updated on 3/7/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Relmada Therapeutics Earnings Date, Estimates & History

Adding

Adding

Adding Relmada Therapeutics, Inc.

Earnings

Relmada Therapeutics Earnings Estimates and Actuals by Quarter

Relmada Therapeutics (NASDAQ:RLMD) Earnings Estimates

Relmada Therapeutics (NASDAQ RLMD) Earnings History by Quarter

30 Days of MarketBeat All Access for $1.00

Premium Research Tools

Market Data and Calendars

Investing Education and Resources